Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from
Omaha, NE
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from
Henderson, NV
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from
Henderson, NV
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from
Rochester, NY
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from
Rochester, NY
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from
High Point, NC
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from
High Point, NC
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigational Site
mi
from
Lake Oswego, OR
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigational Site
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis
mi
from
Portland, OR
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigational Site
mi
from
Austin, TX
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative site
mi
from
Dallas, TX
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from
Charlottesville, VA
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from
Nice,
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from
Nice,
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from
Clinton Township, MI
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from
Clinton Township, MI
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from
Saint Louis, MO
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Axis Clinical Research
mi
from
Los Angeles, CA
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Axis Clinical Research
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Park Avenue Dermatology
mi
from
Orange Park, FL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Park Avenue Dermatology
mi
from
Orange Park, FL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Olympian Clinical Research
mi
from
Tampa, FL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Olympian Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Northwest Clinical Trials
mi
from
Boise, ID
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Northwest Clinical Trials
mi
from
Boise, ID
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Sneeze, Wheeze & Itch Associates LLC
mi
from
Normal, IL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Sneeze, Wheeze & Itch Associates LLC
mi
from
Normal, IL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
The Dermatology Group, P.C.
mi
from
Verona, NJ
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
The Dermatology Group, P.C.
mi
from
Verona, NJ
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
UNC Dermatology and Skin Cancer Center
mi
from
Chapel Hill, NC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
UNC Dermatology and Skin Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Oregon Health and Science University
mi
from
Portland, OR
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
University of Pennsylvania, Department of Dermatology
mi
from
Philadelphia, PA
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
University of Pennsylvania, Department of Dermatology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Temple Itch Center
mi
from
Philadelphia, PA
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Temple Itch Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Radiant Research, Inc.
mi
from
Anderson, SC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Radiant Research, Inc.
mi
from
Anderson, SC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Medical Research South
mi
from
Charleston, SC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Medical Research South
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
National Allergy and Asthma Research, LLC
mi
from
North Charleston, SC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
National Allergy and Asthma Research, LLC
mi
from
North Charleston, SC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Dermatology Treatment & Research Center, PA
mi
from
Dallas, TX
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Dermatology Treatment & Research Center, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Sylvana Research Associates
mi
from
San Antonio, TX
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Sylvana Research Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Clinical research Center of Alabama
mi
from
Birmingham, AL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Clinical research Center of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Forefront Dermatology
mi
from
Carmel, IN
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Forefront Dermatology
mi
from
Carmel, IN
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Corning Center for Clinical Research
mi
from
Corning, NY
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Corning Center for Clinical Research
mi
from
Corning, NY
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Tory Sullivan MD PA
mi
from
North Miami Beach, FL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Tory Sullivan MD PA
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
MediSearch Clinical Trials
mi
from
Saint Joseph, MO
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
MediSearch Clinical Trials
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Florida Center for Dermatology, P.A
mi
from
Jacksonville, FL
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Florida Center for Dermatology, P.A
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Atlanta Dermatology, Vein & Research Ctr
mi
from
Alpharetta, GA
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Atlanta Dermatology, Vein & Research Ctr
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Dermatologic Surgery Specialists, Inc.
mi
from
Macon, GA
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Dermatologic Surgery Specialists, Inc.
mi
from
Macon, GA
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
DermResearch, PLLC
mi
from
Louisville, KY
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
DermResearch, PLLC
mi
from
Louisville, KY
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Tufts Medical Center
mi
from
Boston, MA
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Mass General Hospital Clinical Unit for Research Trials in Skin
mi
from
Boston, MA
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Mass General Hospital Clinical Unit for Research Trials in Skin
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Derm Research Center of New York, Inc.
mi
from
Stony Brook, NY
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Derm Research Center of New York, Inc.
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Oregon Dermatology & Research Center
mi
from
Portland, OR
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Oregon Dermatology & Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Clinical Partners, LLC
mi
from
Johnston, RI
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
J&S Studies
mi
from
College Station, TX
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
J&S Studies
mi
from
College Station, TX
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
University of Utah, Dermatology
mi
from
Salt Lake City, UT
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
University of Utah, Dermatology
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Center for Clinical Studies
mi
from
Webster, TX
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Center for Clinical Studies
mi
from
Webster, TX
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  12/13/2017
Valeant Site 01
mi
from
East Windsor, NJ
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Valeant Site 01
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  12/13/2017
Valeant Site 02
mi
from
High Point, NC
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Valeant Site 02
mi
from
High Point, NC
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  12/13/2017
Valeant Site 03
mi
from
New York, NY
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Valeant Site 03
mi
from
New York, NY
Click here to add this to my saved trials